3.15% (w/v) chlorhexidine gluconate and 70% (v/v) isopropyl alcohol swab for needleless access site disinfection.Accessories & Compliance Tools
- 5 second scrub time followed by 5 second dry time
- 3.15% (w/v) chlorhexidine gluconate (CHG) and 70% (v/v) isopropyl alcohol (IPA)
- Intuitive, easy-to-use prep pad format provides friction to remove microorganisms from grooves and threads of connectors
- Achieved a >4.0 log10 reduction versus a leading alcohol impregnated cap1 against 7 tested clinically relevant microorganisms known to cause CLABSIs2
- Effectively scrub the hub prior to and between each line access, as recommended in the Infusion Nurse Society (INS) Guidelines
- First and only 3.15% CHG/70% IPA swab to receive 510(k) clearance from the US Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use
- Strip format hangs conveniently on an IV pole for point-of-care accessibility
- Disinfecting needleless access sites (needleless connectors, injection ports, and access ports) and tops of blood culture collection bottles.
- Over 15 independent clinical studies demonstrating clinical efficacy of Prevantics products
- US Centers for Disease Control and Prevention
- Infusion Nurses Society
- Society for Healthcare Epidemiology of America
- The Joint Commission National Patient Safety Goals
- Infectious Diseases Society of America
- Association for Professionals in Infection Control and Epidemiology
- Association for Vascular Access
How is Prevantics® Device Swab used?Show Answer
Prevantics Device Swab is designed to disinfect needleless access sites (or to scrub the hub) prior to use as well as in between each line access. Prevantics Device Swab is used to scrub the access site for 5 seconds with drying of the access site for at least 5 seconds.
If I use the Prevantics® Device Swab product, will I still need to use an alcohol impregnated cap?Show Answer
Not necessarily. If clinicians follow all existing infection prevention and control measures, such as hand hygiene, use of personal protective equipment, use of chlorhexidine-based skin antisepsis, etc. then the use of an alcohol impregnated cap may not be clinically indicated. This would be evaluated by ongoing surveillance of HAI rates.
What evidence-based clinical guidelines support the use of the Prevantics® Device Swab for disinfection of needleless access sites prior to use?Show Answer
The following evidence-based clinical guidelines support the use of Chlorhexidine Gluconate/Alcohol for disinfection of needleless access sites prior to use:
1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC)
2. Standards of Practice, Infusion Nurses Society (INS)
3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA)
4. National Patient Safety Goals, The Joint Commission
5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA)
6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC)
Where is Prevantics® Device Swab used?Show Answer
Prevantics Device Swab is used on needleless access sites which include ports, hubs, connectors, dialysis connectors and blood collection applications. These needleless access sites are most commonly found on patients who require an IV (central line, mid-line, or peripheral line).
Why is the Prevantics® Device Swab solution beneficial?Show Answer
By using an antiseptic to disinfect the needleless access site, you are decreasing the risk of the patient acquiring a bloodstream infection (BSI) which can be fatal to the patient. According to the CDC, “Disinfection of the devices with Chlorhexidine /alcohol solution appears to be most effective in reducing colonization”.
Some PDI products state "store at room temperature." What is the definition of room temperature?Show Answer
For our EPA-regulated products, such as Sani-Cloth® and Sani-Prime™ brand products, room temperature is defined as an average temperature of 25◦ C (77◦ F) and within a temperature range of 15◦ C to 30◦ C (59◦ F to 86◦ F). For our FDA-regulated products, such as Prevantics® brand products, “controlled room temperature” indicates a temperature maintained thermostatically that encompasses the usual customary working environment of 20◦ C to 25◦ C (68◦ F to 77◦ F). SOURCE: USP 41-NF 36 General Notices and Requirements (August 1, 2013 First Supplements) Section 10.30.50. “Room Temperature” indicates the temperature prevailing in a working area. Section 10.30.60. Controlled Room Temperature